>Go!

Quarterly Results

Quarterly Results

Quarter Date Title
2Q '17 08.03.2017 Allergan Reports Continued Strong Execution in Second Quarter 2017 with 9% Increase in GAAP Net Revenues to $4.0 Billion
08.03.2017Q2 2017 Allergan plc Earnings Conference Call
1Q '17 05.09.2017 Allergan Reports Solid Start to 2017 with 5% Increase in First Quarter GAAP Net Revenues to $3.6 Billion
05.09.2017Q1 2017 Allergan plc Earnings Conference Call
05.09.2017Q1 2017 Earnings Presentation (PDF)
4Q '16 02.08.2017 Allergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9 Billion in Fourth Quarter 2016
02.08.2017Q4 2016 Allergan plc Earnings Conference Call
3Q '16 11.02.2016 Allergan Reports Third Quarter 2016 Continuing Operations Performance with GAAP Net Revenues of $3.6 Billion; Announces Accelerated Share Repurchase, Initiation of Cash Dividend
11.02.2016Q3 2016 Allergan plc Earnings Conference Call
2Q '16 08.08.2016 Allergan Reports Strong Second Quarter 2016 Continuing Operations Performance with Net Revenues of $3.7 Billion
08.08.2016Q2 2016 Allergan plc Earnings Conference Call
1Q '16 05.10.2016 Allergan Reports Strong First Quarter 2016 Continuing Operations Performance with 48% Increase in Net Revenue to $3.8 Billion and 15% Growth in Non-GAAP Diluted EPS to $3.04
05.10.2016Q1 2016 Allergan plc Earnings Conference Call
05.10.2016Q1 2016 Earnings Presentation (PDF)
4Q '15 02.22.2016 Allergan Reports Exceptional Fourth Quarter 2015 Continuing Operations Performance with 74% Increase in Net Revenue to $4.2 Billion and 33% Growth in Non-GAAP Diluted EPS to $3.41
02.22.2016Q4 2015 Allergan plc Earnings Conference Call
02.22.2016Q4 2015 Earnings Presentation (PDF)
3Q '15 11.04.2015 Allergan Reports Exceptional Third Quarter 2015 Continuing Operations Performance with 90% Increase in Net Revenue to $4.1 Billion and 65% Growth in Non-GAAP EPS to $3.48
11.04.2015Q3 2015 Allergan plc Earnings Conference Call
11.04.2015Q3 2015 Earnings Presentation (PDF)
2Q '15 08.06.2015 Allergan Reports Exceptional Second Quarter 2015 Performance with 116% Increase in Net Revenue to $5.76 Billion and 29% Growth in Non-GAAP EPS to $4.41
08.06.2015Q2 2015 Allergan plc Earnings Conference Call
08.06.2015Q2 2015 Earnings Presentation (PDF)
1Q '15 05.11.2015 Actavis Reports Exceptional Performance in First Quarter 2015 with 59% Increase in Net Revenue to $4.2 Billion and 23% Growth in Non-GAAP EPS to $4.30
05.11.2015Q1 2015 Actavis plc Earnings Conference Call
05.11.2015Q1 2015 Earnings Presentation (PDF)
Page 1 of 4
Electronic Enrollment
Allergan Shareholders: